Ablynx expands into new R&D facility
23-Jun-2010
- Belgium
"This new cutting-edge laboratory building will support Ablynx's growth in the foreseeable future. This allows us to house our Belgian operations in one facility", said Dr Edwin Moses, Chief Executive Officer and Chairman of Ablynx. "With over 240 staff we believe Ablynx is one of the most advanced independent, next-generation biologics companies."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.